phase readout
saveNCT07381465: Efficacy and Safety of IL-1 Inhibitors in Mild to Moderate Systemic Lupus Erythematosus
ACTIVE_NOT_RECRUITINGupdated 10d ago
community read0 votes
Sponsor: Chinese SLE Treatment And Research Group. Phase: PHASE4. Conditions: Lupus Erythematosus, Systemic
view source ↗
comments(0)
5-min edit window · permanent after that